Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-17-007681
Filing Date
2017-04-28
Accepted
2017-04-28 09:22:00
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ceru-10ka_20161231.htm 10-K/A 1111863
2 EX-31.3 ceru-ex313_8.htm EX-31.3 10205
3 EX-31.4 ceru-ex314_9.htm EX-31.4 10090
  Complete submission text file 0001564590-17-007681.txt   1133229
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36395 | Film No.: 17791924
SIC: 2834 Pharmaceutical Preparations